|
Market Closed -
Nasdaq
16:00:00 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 15.32 USD | +6.32% |
|
+4.57% | -33.39% |
| 09-03 | Ionis Pharma prices first FDA-approved treatment for Alexander disease at $285,000 per dose | RE |
| 09-03 | Top Midday Decliners | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +6.32% | +4.57% | -40.18% | -50.21% | -33.39% | -47.32% | -56.44% | -82.39% | -78.59% | 1.42B | |
| -0.85% | -7.40% | -10.59% | +10.68% | -13.34% | +1.58% | -84.91% | -79.73% | -70.04% | 1.99B | |
| -0.32% | -0.11% | -3.23% | +6.41% | -15.08% | -20.46% | -3.43% | - | - | 346M | |
| -12.41% | +28.48% | +31.58% | +27.39% | -18.03% | -26.11% | - | - | - | 80.5M | |
| Average | -1.80% | +7.44% | -5.61% | -1.43% | -19.96% | -23.08% | -48.26% | -81.06% | -74.31% | 957.05M | |
| Weighted average by Cap. | +1.63% | +0.86% | -19.99% | -11.88% | -21.01% | -19.08% | -66.64% | -80.84% | -73.60% |
- Stock Market
- Stocks
- RARE Stock
- Sector Ultragenyx Pharmaceutical Inc.
Select your edition
All financial news and data tailored to specific country editions
